Skip to main content Start of content
43rd Parliament, 2nd Session
(September 23, 2020 - Present)

Canada’s International Trade and Investment Policy: Selected Considerations Concerning COVID-19 Vaccines

First meeting scheduled for: Friday, April 16, 2021

On Friday, March 12, 2021, the committee adopted the following motion:

That, pursuant to Standing Order 108(2), the committee undertake a study of Canada’s trade and investment policy, and trade agreements in respect of how they may help or hinder the production and distribution of COVID-19 vaccines in Canada and across the world, including, but not limited to,

(i) Canada’s position with respect to a proposal at the World Trade Organization to provide “a waiver from certain provisions of the TRIPS Agreement for the prevention, containment and treatment of Covid-19”;

(ii) how Canada’s trade agreements, like CETA, may be used to ensure Canada’s vaccine advance-purchase contracts are respected, and

(iii) whether Canada’s current trade position should motivate accelerated capacity in domestic vaccine manufacturing capability;

That the committee dedicate a minimum of four meetings to this study, and, that the committee report its findings to the House.

The committee is currently receiving submissions from those interested in this topic. Submissions should not exceed 2,000 words. Once received, briefs are translated, distributed to committee members and posted on the committee's website.

Briefs should be submitted to the committee by Friday, April 30, 2021, at the latest.